|
Market Closed -
Australian S.E.
01:10:10 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 1.865 AUD | +7.80% |
|
+1.08% | -44.82% |
Company Valuation: Clarity Pharmaceuticals Ltd
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 131.5 | 182.5 | 1,689 | 803.7 | 798.2 | 695.8 | - | - |
| Change | - | 38.7% | 825.73% | -52.42% | -0.69% | -12.82% | - | - |
| Enterprise Value (EV) 1 | 76.21 | 117.4 | 1,553 | 719.6 | 619.9 | 631.8 | 608.8 | 564.8 |
| Change | - | 54.11% | 1,221.95% | -53.65% | -13.85% | 1.92% | -3.64% | -7.23% |
| P/E | -5.31x | -7.37x | -35x | -12.4x | -7.35x | -5.89x | -7x | 12.9x |
| PBR | 1.37x | 2.64x | 11.5x | 8.91x | 4.23x | 9.48x | 11.4x | 5.04x |
| PEG | - | 7.08x | -0.6x | -0.4x | -0.2x | -0.67x | 0.4x | -0x |
| Capitalization / Revenue | 20.1x | - | - | - | - | - | 21.1x | 1.8x |
| EV / Revenue | 11.6x | - | - | - | - | - | 18.4x | 1.46x |
| EV / EBITDA | -3.22x | -4.81x | -37.1x | -10.5x | -5.44x | -5.13x | -5.99x | 7.2x |
| EV / EBIT | -3.21x | -4.79x | -36.9x | -10.5x | -5.42x | -5.1x | -5.93x | 7.26x |
| EV / FCF | -5.63x | -4.26x | -35.5x | -13.1x | -6.68x | -6.01x | -7.32x | 15.9x |
| FCF Yield | -17.7% | -23.5% | -2.82% | -7.64% | -15% | -16.7% | -13.7% | 6.29% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.096 | -0.095 | -0.155 | -0.201 | -0.291 | -0.3168 | -0.2662 | 0.145 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 6.554 | - | - | - | - | - | 33.03 | 386.7 |
| EBITDA 1 | -23.69 | -24.4 | -41.88 | -68.46 | -114 | -123.2 | -101.6 | 78.4 |
| EBIT 1 | -23.74 | -24.5 | -42.03 | -68.64 | -114.3 | -123.8 | -102.6 | 77.8 |
| Net income 1 | -23.75 | -24.6 | -42.32 | -64.3 | -107.2 | -120.7 | -101.1 | 55.67 |
| Net Debt 1 | -55.34 | -65.01 | -136.5 | -84.12 | -178.3 | -64 | -87 | -131 |
| Reference price 2 | 0.510 | 0.700 | 5.420 | 2.500 | 2.140 | 1.865 | 1.865 | 1.865 |
| Nbr of stocks (in thousands) | 257,939 | 260,663 | 311,646 | 321,472 | 372,971 | 373,081 | - | - |
| Announcement Date | 8/24/22 | 8/24/23 | 8/23/24 | 8/28/25 | 8/27/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.89x | - | -5.13x | - | 484M | |
| 18.77x | 6.69x | 13.41x | 1.58% | 65B | |
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | |
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | |
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | |
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | |
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | |
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | |
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | |
| 30.74x | 5.69x | 19.09x | -.--% | 22.5B | |
| Average | 22.91x | 26.57x | 13.27x | 0.32% | 37.29B | |
| Weighted average by Cap. | 25.93x | 25.01x | 15.46x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CU6 Stock
- Valuation Clarity Pharmaceuticals Ltd
Select your edition
All financial news and data tailored to specific country editions
